Saliva profiles in children with congenital heart disease

Yıl 2020, Cilt: 54 Sayı: 1, 48 - 54, 23.01.2020

Mine Koruyucu Sule Batu Merve Bayram Ezel Uslu Yegane Guven Figen Seymen

https://doi.org/10.26650/eor.20200087

Öz

Purpose The low salivary pH and buffering capacity are caused by using heart failure medications. For this reason oral health should be supported in cardiac patients, it is necessary that they attend dental clinics for regular follow up. The aim of this study is to evaluate the relationship between the salivary oxidative stress markers and salivary pH, salivary buffering capacity, salivary flow rate and dental caries of children with congenital heart disease (CHD). Material and Methods This cross sectional study was carried out with 42 CHD and 42 healthy children. The participants’ gender, age, general health and medications, and caries scores (dfs/ DMFS) were written down, then their unstimulated saliva samples were collected. These specimens were evaluated in terms of the salivary secretion rate, salivary buffering capacity, pH, protein levels, superoxide dismutase (SOD), ferric reducing antioxidant power (FRAP), the thiobarbituric acid reactive substances (TBARS), protein carbonyl, protein thiols, total sialic acid. Results Both groups showed caries at similar levels. The salivary pH and buffering capacity were significantly less in the children with CHD than in the controls. The levels of TBARS and protein carbonyl were significantly higher in the children with CHD than in the controls. There was not any significant difference relating to the mean salivary secretion rate, protein levels, SOD, FRAP, protein thiols and total sialic acid. Conclusion The elevated TBARS and protein carbonyl levels in the patients with CHD were observed as an indicator of the free radical damage leading to oxidative stress.

Anahtar Kelimeler

Saliva composition, antioxidant activity, caries risk factors, congenital cardiac diseases, pedodontics

Destekleyen Kurum

This project was supported by the Research Fund of the Istanbul University.

Proje Numarası

UDP-31219

Teşekkür

The authors thank Dr. Duygu Terzioglu for her assistance in the laboratory analysis of this study. Thanks to the families for their participation. We would also like to thank Selin Meral, Alexandre Rezende Vieira and Elaine Dizak for English grammer check.

Kaynakça

• 1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900. [CrossRef]
• 2. Cameron AC, Widmer RP. Handbook of Pediatric Dentistry 4th Ed.Mosby;. 2013, p.490-4.
• 3. Rosén L, Rydberg A, Sjöström I, Stecksén-Blicks C. Saliva profiles in children using heart failure medication: a pilot study. Eur Arch Paediatr Dent 2010;11:187-91. [CrossRef]
• 4. Koerdt S, Hartz J, Hollatz S, Frohwitter G, Kesting MR, Ewert P, et al. Dental prevention and disease awareness in children with congenital heart disease. Clin Oral Investig 2018;22(3):1487-93. [CrossRef]
• 5. Aizenbud D, Peri-Front Y, Nagler RM. Salivary analysis and antioxidants in cleft lip and palate children. Arch Oral Biol 2008;53:517-22. [CrossRef]
• 6. Foley JD, Sneed JD, Steinhubl SR, Kolasa J, Ebersole JL, Lin Y, et al. Oral fluids that detect cardiovascular disease biomarkers. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:207-14. [CrossRef]
• 7. Dekker RL, Lennie TA, Moser DK, Miller CS, Ebersole JL, Chung ML, et al. Salivary Biomarkers, Oral Inflammation, and Functional Status in Patients With Heart Failure. Biol Res Nurs 2017;19:15361. [CrossRef]
• 8. Hamilton C, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, et al. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 2004;106:219-34. [CrossRef]
• 9. Jain AK, Mehra NK, Swarnakar NK. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des 2015;21:4441-55. [CrossRef]
• 10. Tóthová L, Kamodyová N, Červenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol 2015;20:-73. [CrossRef]
• 11. Tulunoglu Ö, Demirtas S, Tulunoglu I. Total antioxidant levels of saliva in children related to caries, age, and gender. Int J Paediatr Dent 2006;16:186-91. [CrossRef]
• 12. Ericsson Y. Clinical investigations of the salivary buffering action. Acta Odontol Scand 1959;17:131-65. [CrossRef]
• 13. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85. [CrossRef]
• 14. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
• 15. Benzie IFF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27. [CrossRef]
• 16. Higueras V, Raya Á, Rodrigo J, Serra MÁ, Romá J, Romero FJ. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic Biol Med 1994;16:131-3. [CrossRef]
• 17. Reznick AZ, Shehadeh N, Shafir Y, Nagler RM. Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus. Arch Oral Biol 2006;51:640-8. [CrossRef]
• 18. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7. [CrossRef]
• 19. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205. [CrossRef]
• 20. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 1961;81:384-92. [CrossRef]
• 21. Skoza L, Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J 1976;159:457-62. [CrossRef]
• 22. Tram TH, Brand Miller JC, McNeil Y, McVeagh P. Sialic acid content of infant saliva: Comparison of breast fed with formula fed infants. Arch Dis Child 1997;77:315-8. [CrossRef]
• 23. Dasanayake AP, Roseman JM, Caufield PW, Butts JT. Distribution and determinants of mutans streptococci among AfricanAmerican children and association with selected variables. Pediatr Dent 1995;17:192-8.
• 24. Grahn K, Wikström S, Nyman L, Rydberg A, Stecksén-Blicks C. Attitudes about dental care among parents whose children suffer from severe congenital heart disease: a case-control study. Int J Paediatr Dent 2006;16:231-8. [CrossRef]
• 25. Nunn JH, Ng SKF, Sharkey I, Coulthard M. The dental implications of chronic use of acidic medicines in medically compromised children. Pharm World Sci 2001;23:118-9. [CrossRef]
• 26. Ahmed AF, El-Maraghy NN, Abdel Ghaney RH, Elshazly SM. Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats. Saudi J Gastroenterol 2012;18:182-7. [CrossRef]
• 27. Sheng R, Gu ZL, Xie ML. Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy. Int J Cardiol 2013;162:199-209. [CrossRef]
• 28. Tsuber V, Kadamov Y, Tarasenko L. Activation of antioxidant defenses in whole saliva by psychosocial stress is more manifested in young women than in young men. PLoS One 2014; 19;9(12):e115048. [CrossRef]
• 29. Hegde AM, Kavita R, Sushma KS, Suchetha S. Salivary sialic acid levels and dental health in children with congenital heart disease. J Clin Pediatr Dent 2012;36:293-6. [CrossRef]